Attached files
| file | filename |
|---|---|
| 10-Q - RADIENT PHARMACEUTICALS Corp | v194198_10q.htm |
| EX-31.2 - RADIENT PHARMACEUTICALS Corp | v194198_ex31-2.htm |
| EX-31.1 - RADIENT PHARMACEUTICALS Corp | v194198_ex31-1.htm |
| EX-32.1 - RADIENT PHARMACEUTICALS Corp | v194198_ex32-1.htm |
Exhibit
32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the quarterly report of Radient Pharmaceuticals Corporation (the
“Company”) on Form 10-Q for the period ended June 30, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Akio
Ariura, Principal Financial Officer and Secretary of the Company, certify,
pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the
United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
Date:
August 17, 2010
|
/s/
Akio Ariura
|
|
|
Akio
Ariura
|
||
|
Chief
Financial Officer and Secretary
|
||
|
(Principal
Financial Officer)
|
||
|
Radient
Pharmaceuticals Corporation
|
A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.
This
certification accompanies this Quarterly Report on Form 10-Q pursuant to Section
906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent
required by such Act, be deemed filed by the Company for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such
certification will not be deemed to be incorporated by reference into any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except to the
extent that the Company specifically incorporates it by
reference.